Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-18
DOI
10.1038/s41598-017-02631-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
- (2016) Weijian Ke et al. Journal of Diabetes Research
- Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
- (2014) Lalitha Gudipaty et al. DIABETES CARE
- Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial
- (2014) Ravi Retnakaran et al. DIABETES CARE
- Early therapy for type 2 diabetes in China
- (2014) Wenying Yang et al. Lancet Diabetes & Endocrinology
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)
- (2013) J. Rosenstock et al. DIABETES CARE
- A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin based therapy
- (2013) Regin Elsa George et al. SAUDI PHARMACEUTICAL JOURNAL
- Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis
- (2013) Caroline Kaercher Kramer et al. Lancet Diabetes & Endocrinology
- Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment
- (2012) A. Chen et al. DIABETES CARE
- Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy
- (2012) Liehua Liu et al. Diabetes Technology & Therapeutics
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- Effects of Exenatide on Measures of -Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
- (2011) M. C. Bunck et al. DIABETES CARE
- One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
- (2009) M. C. Bunck et al. DIABETES CARE
- Exenatide efficacy and safety: a systematic review
- (2009) S. L. Norris et al. DIABETIC MEDICINE
- Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
- (2008) Vincent Poitout et al. ENDOCRINE REVIEWS
- Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
- (2008) Jianping Weng et al. LANCET
- Weight Loss Therapy Improves Pancreatic Endocrine Function in Obese Older Adults
- (2008) Dennis T. Villareal et al. Obesity
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now